Form 8-K - Current report:
SEC Accession No. 0000950170-24-120154
Filing Date
2024-11-01
Accepted
2024-11-01 17:10:08
Documents
12
Period of Report
2024-10-28
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K itrm-20241028.htm   iXBRL 8-K 45241
2 EX-10.1 itrm-ex10_1.htm EX-10.1 20941
  Complete submission text file 0000950170-24-120154.txt   190785

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20241028.xsd EX-101.SCH 26763
14 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20241028_htm.xml XML 4891
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 241419965
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)